Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Transplantation

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    November 2021
  1. DE VILLE DE GOYET J, Baumann U, Karam V, Adam R, et al
    European Liver Transplant Registry: donor and transplant surgery aspects of 16,641 liver transplantations in children.
    Hepatology. 2021 Nov 1. doi: 10.1002/hep.32223.
    PubMed     Abstract available


    October 2021
  2. BEKKI Y, Fenig Y
    Outcomes of Severe Alcohol-Related Hepatitis with or without Early Liver Transplantation.
    Hepatology. 2021 Oct 30. doi: 10.1002/hep.32219.
    PubMed     Abstract available


  3. DE GOEIJ FHC, Schlegel A, Dutkowski P
    Reply to: Short-term data on machine perfusion for liver transplantation should be extrapolated with caution.
    Hepatology. 2021 Oct 8. doi: 10.1002/hep.32192.
    PubMed     Abstract available


    September 2021
  4. BLOOM PP, Fontana RJ
    With Alcohol as the fuel, COVID is the match: Liver Transplantation for Alcoholic liver disease is increasing in the United States.
    Hepatology. 2021 Sep 8. doi: 10.1002/hep.32141.
    PubMed     Abstract available


  5. RAEVENS S, Boret M, De Pauw M, Fallon MB, et al
    Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.
    Hepatology. 2021;74:1674-1686.
    PubMed     Abstract available


    August 2021
  6. VARGHESE J, Malleswaran S, Mouleeswaran K
    Letter to the Editor: Toxin-induced Graft Injury following Liver Transplantation for Yellow Phosphorus Poisoning.
    Hepatology. 2021 Aug 28. doi: 10.1002/hep.32124.
    PubMed     Abstract available


  7. HAKEEM A, Rammohan A, Vij M, Rela M, et al
    Insights into Yellow Phosphorus Induced Graft Injury following Liver Transplantation.
    Hepatology. 2021 Aug 27. doi: 10.1002/hep.32127.
    PubMed     Abstract available


  8. WADHWANI SI, Ge J, Gottlieb L, Lyles C, et al
    Racial/Ethnic Disparities in Wait List Outcomes Are Only Partly Explained by Socioeconomic Deprivation Among Children Awaiting Liver Transplantation.
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32106.
    PubMed     Abstract available


  9. MUSTO J, Stanfield D, Ley D, Lucey MR, et al
    Recovery and Outcomes of Patients Denied Early Liver Transplantation (LT) for Severe Alcohol-Related Hepatitis (AH).
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32110.
    PubMed     Abstract available


  10. FIX OK, Blumberg EA, Chang KM, Chu J, et al
    American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
    Hepatology. 2021;74:1049-1064.
    PubMed     Abstract available


    July 2021
  11. WADHWANI SI, Gottlieb L, Bucuvalas JC, Lyles C, et al
    Addressing social adversity to improve outcomes for children after liver transplant.
    Hepatology. 2021 Jul 28. doi: 10.1002/hep.32073.
    PubMed     Abstract available


  12. CHOLANKERIL G, Goli K, Rana A, Hernaez R, et al
    Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the United States.
    Hepatology. 2021 Jul 26. doi: 10.1002/hep.32067.
    PubMed     Abstract available


  13. DE GOEIJ FHC, Schlegel A, Muiesan P, Guarrera JV, et al
    Hypothermic oxygenated machine perfusion protects from cholangiopathy in DCD liver transplantation.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32044.
    PubMed     Abstract available


    June 2021
  14. HIRAO H, Ito T, Kadono K, Kojima H, et al
    Donor Hepatic Occult Collagen Deposition Predisposes to Peri-transplant Stress and Impacts Human Liver Transplantation.
    Hepatology. 2021 Jun 25. doi: 10.1002/hep.32030.
    PubMed     Abstract available


  15. WONG TC, Lee VH, Law AL, Pang HH, et al
    Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant.
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31992.
    PubMed     Abstract available


  16. ROSENBLATT R, Lee H, Liapakis A, Lunsford KE, et al
    Equitable access to liver transplant: Bridging the gaps in the social determinants of health.
    Hepatology. 2021 Jun 1. doi: 10.1002/hep.31986.
    PubMed     Abstract available


    May 2021
  17. MARTINEZ M, Perito ER, Valentino P, Mack CL, et al
    Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31911.
    PubMed     Abstract available


  18. MEUNIER L, Faure S, Meszaros M
    Letter to the Editor: Cancer after liver transplant: don't forget tobacco and tacrolimus.
    Hepatology. 2021 May 15. doi: 10.1002/hep.31899.
    PubMed     Abstract available


    March 2021
  19. ROSENBLATT R, Wahid N, Halazun KJ, Kaplan A, et al
    Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Hepatology. 2021 Mar 29. doi: 10.1002/hep.31837.
    PubMed     Abstract available


  20. VANDERWERKEN D, Wood NL, Segev D, Gentry S, et al
    The Precise Relationship Between MELD and Survival Without a Liver Transplant.
    Hepatology. 2021 Mar 2. doi: 10.1002/hep.31781.
    PubMed     Abstract available


    February 2021
  21. HERCUN J, Parikh E, Kleiner DE, Fuss I, et al
    Recurrent nodular regenerative hyperplasia post-liver transplantation in common variable immunodeficiency.
    Hepatology. 2021 Feb 27. doi: 10.1002/hep.31775.
    PubMed     Abstract available


  22. NASSER-GHODSI N, Mara K, Watt KD
    De novo Colorectal and Pancreatic Cancer in Liver Transplant Recipients: Identifying the Higher Risk Populations.
    Hepatology. 2021 Feb 5. doi: 10.1002/hep.31731.
    PubMed     Abstract available


  23. CHEN SY, Zhang HP, Li J, Shi JH, et al
    Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor beta-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
    Hepatology. 2021;73:738-758.
    PubMed     Abstract available


    January 2021
  24. JIN L, Li X
    Letter to the Editor: Prognostic value of B-type natriuretic peptide in liver transplant patients.
    Hepatology. 2021 Jan 18. doi: 10.1002/hep.31721.
    PubMed     Abstract available


  25. KWON HM, Jang HY, Hwang GS
    Reply to Letter to the Editors: "Prognostic value of B-type natriuretic peptide in liver transplant patients".
    Hepatology. 2021 Jan 18. doi: 10.1002/hep.31722.
    PubMed     Abstract available


  26. SARKAR M, Brady CW, Fleckenstein J, Forde KA, et al
    Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:318-365.
    PubMed    


  27. LEONIS MA, Miethke AG, Fei L, Maynor S, et al
    Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
    Hepatology. 2021;73:233-246.
    PubMed     Abstract available


    November 2020
  28. HAFEZI M, Lin M, Chia A, Chua A, et al
    Immunosuppressive Drug Resistant Armored TCR T cells for immune-therapy of HCC in liver transplant patients.
    Hepatology. 2020 Nov 29. doi: 10.1002/hep.31662.
    PubMed     Abstract available


  29. KWON HM, Moon YJ, Kim KS, Shin WJ, et al
    Prognostic value of B-type natriuretic peptide in liver transplant patients: Implication in post-transplant mortality.
    Hepatology. 2020 Nov 28. doi: 10.1002/hep.31661.
    PubMed     Abstract available


  30. BARMAN PM, VanWagner LB
    Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.
    Hepatology. 2020 Nov 20. doi: 10.1002/hep.31647.
    PubMed     Abstract available


  31. POLI E, Verstuyft C, Guettier C, Duclos Vallee JC, et al
    Reply to "Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and immunosuppressive drugs: causality of MMF or tacrolimus?"
    Hepatology. 2020 Nov 17. doi: 10.1002/hep.31635.
    PubMed     Abstract available


  32. LOUSTAUD-RATTI V, Anneraud A, Carrier P, Debette-Gratien M, et al
    Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and immunosuppressive drugs: causality of MMF or tacrolimus?
    Hepatology. 2020 Nov 13. doi: 10.1002/hep.31633.
    PubMed     Abstract available


    October 2020
  33. BROWN SA, Izzy M, Watt KD
    Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underutilized Potential.
    Hepatology. 2020 Oct 12. doi: 10.1002/hep.31595.
    PubMed     Abstract available


  34. WONG TC, Yan-Yue Fung J, Pang HH, Leung CK, et al
    Analysis of survival benefits of living vs. deceased donor liver transplant in high MELD and hepatorenal syndrome.
    Hepatology. 2020 Oct 2. doi: 10.1002/hep.31584.
    PubMed     Abstract available


    September 2020
  35. RABIEE A, Sadowski B, Adeniji N, Perumalswami P, et al
    Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience.
    Hepatology. 2020 Sep 22. doi: 10.1002/hep.31574.
    PubMed     Abstract available


  36. JASPER S, Hakeem AR, Vij M, Sachan D, et al
    First report of toxin-induced graft injury following liver transplantation for Yellow Phosphorus Poisoning.
    Hepatology. 2020 Sep 16. doi: 10.1002/hep.31553.
    PubMed     Abstract available


  37. PIANO S, Gambino C, Vettore E, Calvino V, et al
    Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Hepatology. 2020 Sep 1. doi: 10.1002/hep.31529.
    PubMed     Abstract available


  38. DA BL, Im GY, Schiano TD
    Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Hepatology. 2020;72:1102-1108.
    PubMed     Abstract available


    August 2020
  39. FENG S, Bucuvalas JC, Mazariegos GV, Magee JC, et al
    Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Towards Personalized Management.
    Hepatology. 2020 Aug 12. doi: 10.1002/hep.31520.
    PubMed     Abstract available


  40. KIM WH, Yang SM, Lee KH
    Letter to the Editor: Appraisal of Cardiac Ejection Fraction With Liver Disease Severity.
    Hepatology. 2020;72:783.
    PubMed    


  41. KWON HM, Hwang GS
    Reply.
    Hepatology. 2020;72:784.
    PubMed    


    July 2020
  42. REIBERGER T, Mandorfer M
    "Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient".
    Hepatology. 2020 Jul 12. doi: 10.1002/hep.31458.
    PubMed     Abstract available


  43. THAN NN, Cataluna JG, Majumdar A
    Acute confusion post liver transplantation: HE or not HE, that is the question.
    Hepatology. 2020 Jul 6. doi: 10.1002/hep.31452.
    PubMed     Abstract available


    June 2020
  44. COTTER TG, Wang J, Peeraphatdit T, Sandikci B, et al
    Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the USA: Rapidly Increasing with Acceptable Outcomes.
    Hepatology. 2020 Jun 19. doi: 10.1002/hep.31426.
    PubMed     Abstract available


  45. RUSSO MW, Fix OK, Koteish AA, Duggan K, et al
    Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage.
    Hepatology. 2020 Jun 17. doi: 10.1002/hep.31425.
    PubMed     Abstract available


  46. KARDASHIAN A, Ge J, McCulloch CE, Kappus MR, et al
    Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Hepatology. 2020 Jun 3. doi: 10.1002/hep.31406.
    PubMed     Abstract available


  47. THALJI L, Thalji NM, Heimbach JK, Ibrahim SH, et al
    Renal Function Parameters and Serum Sodium Enhance Prediction of Waitlist Outcomes in Pediatric Liver Transplantation.
    Hepatology. 2020 Jun 2. doi: 10.1002/hep.31397.
    PubMed     Abstract available


    May 2020
  48. DENEAU MR, Mack C, Perito ER, Ricciuto A, et al
    The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) index: a prognostic tool for children.
    Hepatology. 2020 May 28. doi: 10.1002/hep.31393.
    PubMed     Abstract available


  49. SOSA RA, Terry AQ, Kaldas FM, Jin YP, et al
    Disulfide-HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.
    Hepatology. 2020 May 19. doi: 10.1002/hep.31324.
    PubMed     Abstract available


  50. GABR A, Kulik L, Mouli S, Riaz A, et al
    Liver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort.
    Hepatology. 2020 May 16. doi: 10.1002/hep.31318.
    PubMed     Abstract available


    April 2020
  51. CHOI J, Jo C, Lim YS
    Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection.
    Hepatology. 2020 Apr 23. doi: 10.1002/hep.31289.
    PubMed     Abstract available


  52. KUMAR A
    Letter to the Editor: Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?
    Hepatology. 2020 Apr 22. doi: 10.1002/hep.31285.
    PubMed     Abstract available


  53. KARDASHIAN A, Agopian V
    Reply to: "Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?"
    Hepatology. 2020 Apr 20. doi: 10.1002/hep.31283.
    PubMed     Abstract available


  54. FIX OK, Hameed B, Fontana RJ, Kwok RM, et al
    Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
    Hepatology. 2020 Apr 16. doi: 10.1002/hep.31281.
    PubMed     Abstract available


  55. KHALAF RT, Sokol RJ
    New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Hepatology. 2020;71:1486-1498.
    PubMed     Abstract available


    March 2020
  56. QIN J, Wang H, Qin X, Zhang P, et al
    Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.
    Hepatology. 2020 Mar 27. doi: 10.1002/hep.31257.
    PubMed     Abstract available


  57. SCHWACHA-EIPPER B, Minciuna I, Banz V, Dufour JF, et al
    Immunotherapy as a downstaging therapy for liver transplantation.
    Hepatology. 2020 Mar 14. doi: 10.1002/hep.31234.
    PubMed     Abstract available


  58. NAGAI S, Kitajima T, Yeddula S, Salgia R, et al
    Effect of mandatory 6-month waiting period on waitlist and transplant outcomes in patients with hepatocellular carcinoma.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31223.
    PubMed     Abstract available


  59. KARDASHIAN A, Florman SS, Haydel B, Ruiz RM, et al
    Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Hepatology. 2020 Mar 2. doi: 10.1002/hep.31210.
    PubMed     Abstract available


  60. TANER T, Heimbach JK
    Something Wicked this Way Comes.
    Hepatology. 2020;71:1119-1121.
    PubMed    


  61. SPANN A, Yasodhara A, Kang J, Watt K, et al
    Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review.
    Hepatology. 2020;71:1093-1105.
    PubMed     Abstract available


    February 2020
  62. JUNGER H, Knoppke B, Weigand K, Evert K, et al
    Living donor liver transplantation from hepatitis C-infected donor to hepatitis C-infected recipient.
    Hepatology. 2020 Feb 17. doi: 10.1002/hep.31185.
    PubMed     Abstract available


  63. DEROO R, Trepo E, Holvoet T, De Pauw M, et al
    Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31164.
    PubMed     Abstract available


    January 2020
  64. WALLACE D, Cowling T, PcPhail MJ, Brown SE, et al
    Assessing the time-dependent impact of performance status on outcomes after liver transplantation.
    Hepatology. 2020 Jan 22. doi: 10.1002/hep.31124.
    PubMed     Abstract available


  65. KOLB JM, Conzen K, Wachs M, Crossno J Jr, et al
    Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
    Hepatology. 2020 Jan 14. doi: 10.1002/hep.31111.
    PubMed     Abstract available


  66. CRABB DW, Im GY, Szabo G, Mellinger JL, et al
    Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.
    Hepatology. 2020;71:306-333.
    PubMed    


    December 2019
  67. DERY KJ, Nakamura K, Kadono K, Hirao H, et al
    Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplant Injury.
    Hepatology. 2019 Dec 27. doi: 10.1002/hep.31093.
    PubMed     Abstract available


  68. DEVARBHAVI H
    Response to "Liver Transplantation for Acute Liver Failure Due to Dengue Fever" by Galante A et al. Hepatology. 2019;70:1863-65.
    Hepatology. 2019 Dec 17. doi: 10.1002/hep.31074.
    PubMed     Abstract available


    November 2019
  69. GYORI GP, Pereyra D, Rumpf B, Hackl H, et al
    Von Willebrand factor facilitates MELD-independent risk stratification on the waiting list for liver transplantation.
    Hepatology. 2019 Nov 27. doi: 10.1002/hep.31047.
    PubMed     Abstract available


  70. LEVITSKY J, Burrell BE, Kanaparthi S, Turka LA, et al
    Immunosuppression withdrawal in liver transplant recipients on sirolimus.
    Hepatology. 2019 Nov 13. doi: 10.1002/hep.31036.
    PubMed     Abstract available


  71. LEE BP, Vittinghoff E, Pletcher MJ, Dodge JL, et al
    Medicaid Policy and Liver Transplant for Alcohol-Related Liver Disease.
    Hepatology. 2019 Nov 8. doi: 10.1002/hep.31027.
    PubMed     Abstract available


  72. KUTKUT I, Rachwan RJ, Timsina LR, Ghabril MS, et al
    Pre-Liver Transplant Cardiac Catheterization is Associated with Low Rate of Myocardial Infarction and Cardiac Mortality.
    Hepatology. 2019 Nov 7. doi: 10.1002/hep.31023.
    PubMed     Abstract available


    October 2019
  73. KAPILA N, Menon KVN, Al-Khalloufi K, Vanatta JM, et al
    HCV NAT positive solid organ allografts transplanted into HCV negative recipients: A real-world experience.
    Hepatology. 2019 Oct 28. doi: 10.1002/hep.31011.
    PubMed     Abstract available


  74. POLI E, Kounis I, Guettier C, Verstuyft C, et al
    Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil.
    Hepatology. 2019 Oct 9. doi: 10.1002/hep.30984.
    PubMed     Abstract available


    September 2019
  75. SIDDIQUI MB, Siddiqui MS
    Reply letter for: HEP-18-1513.R3 - Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events In Liver Transplant Recipients.
    Hepatology. 2019 Sep 26. doi: 10.1002/hep.30971.
    PubMed     Abstract available


  76. WANG P, Zhong L
    Lipoproteins Sub-particles and Cardiovascular Risk In liver transplantation: More details, More Significance.
    Hepatology. 2019 Sep 26. doi: 10.1002/hep.30972.
    PubMed     Abstract available


  77. KIM HB, Elisofon SA
    Hepatology Elsewhere.
    Hepatology. 2019 Sep 13. doi: 10.1002/hep.30935.
    PubMed     Abstract available


    December 2018
  78. GOODE EC, Clark AB, Mells GM, Srivastava B, et al
    Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
    Hepatology. 2018 Dec 19. doi: 10.1002/hep.30479.
    PubMed     Abstract available


  79. SOLGA SF, Serper M, Young RA, Forde KA, et al
    Transplantation for Alcoholic Hepatitis: Are We Achieving Justice and Utility?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30471.
    PubMed     Abstract available


  80. MEHTA N, Dodge JL, Roberts JP, Hirose R, et al
    Alpha-fetoprotein Decrease from >1000 to <500 ng/ml in Patients with Hepatocellular Carcinoma Leads to Improved Post-Transplant Outcomes.
    Hepatology. 2018 Dec 13. doi: 10.1002/hep.30413.
    PubMed     Abstract available


  81. RAND EB
    Cirrhotic Cardiomyopathy in children with BA: A new objective parameter to predict morbidity and mortality on the waitlist - and beyond!
    Hepatology. 2018 Dec 12. doi: 10.1002/hep.30419.
    PubMed     Abstract available


  82. SIMONETTO DA, Piccolo Serafim L, Gallo de Moraes A, Gajic O, et al
    Management of Sepsis in Patients with Cirrhosis: current evidence and practical approach.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30412.
    PubMed     Abstract available


  83. BALE R, Schullian P, Eberle G, Putzer D, et al
    Stereotactic radiofrequency ablation of hepatocellular carcinoma - A histopathological study in explanted livers.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30406.
    PubMed     Abstract available


  84. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Ghabril M, et al
    Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30368.
    PubMed     Abstract available


    September 2018
  85. RAEVENS S, Colle I
    Why pulse oximetry is inaccurate in liver cirrhosis - ancient knowledge.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30260.
    PubMed     Abstract available


  86. KIM JD, Cho EJ, Ahn C, Park SK, et al
    A Novel Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30262.
    PubMed     Abstract available


    August 2018
  87. ALLEGRETTI AS, Parada XV, Ortiz GA, Long J, et al
    Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30230.
    PubMed     Abstract available


    September 2017
  88. MARSHALL K, Jin J, Atkinson C, Alawieh A, et al
    Natural IgM initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29512.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: